In a recent study, Iwama et al. (2022) explored the role of T-DM1 in patients with NSCLC whose HER2 was activated by an ex vivo exon 20 insertion mutation, which is detected by NGS. Here, ERBB2 is linked to non-small cell lung carcinoma.